• Korean Journal of Veterinary Research
• /
• v.19 no.1
• /
• pp.69-73
• /
• 1979

In order to detect the influence of overdosed combelen on the Korean native goats, 5mg of combelen per kg of body weight were injected intramusculary. Clinical findings, electrocardiograms and some blood chemical values were determined and the results obtained were as follows: 1. After administration of 5 mg/kg dose of combelen the animals were moderately depressed and often tried to take sitting position but showed moderate response to pinching stimulation of skin. 2. Body temperature and respiratory rate were not suppressed but heart rate were accelerated during sedative stage. 3. During sedation a slight change in the QRS complex and T wave appeared but it was not significant. 4. Hemoglobin concentration showed a tendency to decrease. SGOT activities were markedly increased 24 hours after administration of combelen and BUN values were slightly lowered. Blood sugar values were markedly elevated during sedative stage.

• Korean Journal of Veterinary Research
• /
• v.18 no.1
• /
• pp.1-7
• /
• 1978

In order to detect the clinical effect of combelen which is used for sedation of domestic animals, 10 heads of clinically healthy Korean native goats were used in this study. They were divided into two groups; one is dose level of 1ml per 10 kg of body weight with 1% combelen and the other is dose level of 3 ml. Clinical observations and changes in blood components after administration of combelen were made. 1. There was no adverse effect due to combelen, but sedative effect was insufficient. 2. During sedative period the changes in heart rate and respiratory rate showed noticeable change, and body temperature was slightly decreased. 3. In ECG recordings, except for slight changes in T wave, significant change was not observed. 4. Erythrocytes, leukocytes, hemoglobin concentration and packed cell volume showed tendency to decrease during the period of sedation. 5. SGOT activity showed a remarkable increase and BUN showed a great decrease 24 hours after administration in the group of 3ml/10kg. Blood glucose level increased during the period of sedation in both groups.

• Journal of Pharmaceutical Investigation
• /
• v.22 no.3
• /
• pp.197-204
• /
• 1992

A gas chromatographic method using nitrogen phosphorous selective detection was developed for simultaneous determination of haloperidol and its metabolite, reduced haloperidol, in human plasma. Combelen was used as internal standard, The method involved extraction and trimethylsilylation followed by the injection of $2-4\;{\mu}l$ of benzene layer, which was used to dissolve the trimethylsilylated derivatives of haloperidol and reduced haloperidol, onto SE-54 column [5% phenyl methyl silica fused capillary column, $16m{\times}0.22\;mm$ $(I.D.){\times}0.33\;{\mu}m$ (coated thickness)]. The temperature of column oven was programmed from $200^{\circ}C\;to\;300^{\circ}C$ at the increase rate of $10^{\circ}C/min and also the temperatures of injector and detector were set at $300^{\circ}C$. Helium was used as carrier gas and its flow rate was maintained at 30 ml/min. The detection was conducted with nitrogen phosphorous selective detector. The retention times for combelen, reduced haloperidol and haloperidol were found to be 9.14, 9.75 and 9.99 min, respectively. The detection limits for haloperidol and reduced haloperidol in human plasma were both 0.2 ng/ml. The coefficients of variation of the intra-assay were generally low (below 9.8%). The mean absolute recoveries of added haloperidol and reduced haloperidol from plasma were 72% and 84%, respectively. No interferences from endogenous substances were found.